Globaldata

DATA · Main Market · Industrial Goods and Services · mcap £390m · 59.3p

GlobalData sells subscription data, analytics and research to companies in sectors such as healthcare, technology and finance. Most revenue is recurring and comes from annual contracts.

Target	Promise	Said	Status
2024
31 Oct 2024	Complete £10m share buyback by 31 October 2024.	31 Jul 2024	✓ Kept
	“the Board has approved a return of surplus capital of £10 million to shareholders to be implemented through a share buyback programme” Result Completed 6 September 2024 at 221.5p average. “Following the above transaction, the Group has completed the Share Buyback Programme which was announced on 31 July 2024. In total, the Group repurchased 4,513,867 ordinary shares of £0.0001, all of which were cancelled, at a total cost of £10 million.”6 Sep 2024 · Completion of Share Buyback Programme
Q2 2024	De-leverage to net cash after the Healthcare stake sale completes.	21 Dec 2023	✓ Kept
	“it is anticipated that GlobalData's balance sheet will go from net debt of £230.8m to being debt-free and net cash.” Result Completed June 2024; net cash £188.3m at half-year 2024. “Group now in net cash position of £188.3m.”31 Jul 2024 · Half-year Results “Furthermore, on completion of this transaction the Group's existing debt facilities were fully settled and extinguished, leaving GlobalData with a net cash balance sheet providing additional flexibility for accelerated value-creating M&A activity.”31 Jul 2024 · Half-year Results
2025
17 Jan 2025	Complete £20m share buyback by 17 January 2025.	23 Sep 2024	✓ Kept
	Result The £50m buyback announcement refers to £30m returned across the two completed programmes. “This follows the two share buyback programmes which completed on 5 September 2024 and 13 January 2025 respectively and which returned an aggregate amount of £30 million to shareholders.”6 Feb 2025 · Proposed move to the Main Market
31 Aug 2025	Complete £50m share buyback by 31 August 2025.	6 Feb 2025	◐ Partly kept
	“The Share Buyback Programme will run from the date of this announcement until the earlier of (i) the date when the full £50 million has been returned to shareholders and (ii) 31 August 2025” Result Suspended 2 May 2025 on entering the offer period; later returns came via a £60m tender offer. “The total value to be returned to Shareholders pursuant to the Tender Offer will therefore be approximately £60 million.”8 Sep 2025 · Results of Tender Offer and Total Voting Rights
5 Sep 2025	Return up to £60m by tender offer by 5 September 2025.	5 Aug 2025	✓ Kept
	“proposing to return up to £60 million to Shareholders by way of a Tender Offer” Result 40m shares bought at 150p for £60m, completed 8 September 2025. “a total of 40,000,000 Shares will be purchased under the Tender Offer at the Tender Price of £1.50 per Share. The total value to be returned to Shareholders pursuant to the Tender Offer will therefore be approximately £60 million.”8 Sep 2025 · Results of Tender Offer and Total Voting Rights “It is anticipated that payment of the consideration due to Qualifying Shareholders whose tender applications under the Tender Offer have been accepted will be despatched (by cheque or by a CREST payment, as appropriate) on or before 22 September 2025.”8 Sep 2025 · Results of Tender Offer and Total Voting Rights
31 Dec 2025	Regain a normalised EBITDA margin in H2 2025.	15 Jul 2025	✗ Missed · target changed
	“We expect to return to a normalised margin through the second half.” Also stated 5 Aug 2025 Result October 2025 cut H2 margin guidance to about 37%; FY25 margin was 34%. “With continued investment in the second half and the acquired businesses being integrated more slowly than expected, the second half Adjusted EBITDA margin is now expected to be lower than previously anticipated at approximately 37% (H1 2025 33%).”20 Oct 2025 · Trading Update and Capital Markets Event “Adjusted EBITDA of £110.2m (2024: £116.8m) and margin of 34% (2024: 41%) reflect the impact of investments in Growth Transformation Plan initiatives, including sales expansion and senior leadership strengthening, alongside the short-term dilutive impact of six acquisitions during their initial integration phase.”2 Mar 2026 · Final Results
31 Dec 2025	Deliver £8m EBITDA from FY24 acquisitions in H2 2025.	15 Jul 2025	… In progress
	“expected to provide £8.0m of Adjusted EBITDA contribution through the second half of the year” Also stated 5 Aug 2025 Result Not yet due.
31 Dec 2025	Complete move to the Main Market by Q4 2025.	15 Jul 2025	✗ Missed
	“Subject to the necessary conditions and regulatory approvals being met, Admission is expected to occur before the end of this year, but not earlier than on or around 28 October 2025” Also stated 25 Sep 2025 Result Timing was pushed back; admission occurred on 5 March 2026. “Subject to the necessary conditions and regulatory approvals being met, Admission is expected to occur before the end of this year, but not earlier than on or around 28 October 2025”25 Sep 2025 · Update on proposed move to the Main Market
31 Dec 2025	Deliver low single-digit underlying revenue growth for FY25.	20 Oct 2025	✓ Kept
	“we continue to expect to deliver low single-digit underlying revenue growth for FY25, in line with the market consensus” Result FY25 underlying revenue growth was 1%. “Total revenue growth of 13% to £322.1m (2024: £285.5m), underlying revenue growth1 of 1%.”2 Mar 2026 · Final Results
31 Dec 2025	Reach run-rate cost synergies from acquisitions and the plan by end FY25.	20 Oct 2025	… In progress
	“The recent acquisitions and the GTP are expected to achieve expected run-rate cost synergies by the end of FY25” Result Not yet due.
2026
28 Apr 2026	Complete £10m buyback before the next AGM.	24 Nov 2025	✓ Kept
	“expected to be completed prior to the Company's next Annual General Meeting” Result A further £10m programme launched 31 March 2026, suggesting the first was completed. “GlobalData Plc is pleased to announce a new share buyback programme of up to a maximum consideration of £10 million (the 'Share Buyback Programme'), within certain pre-set parameters.”31 Mar 2026 · Launch of new £10 million Share Buyback Programme “taking into account the Company's previous share buyback activity”31 Mar 2026 · Launch of new £10 million Share Buyback Programme
10 Aug 2026	Return up to £30m by tender offer by 10 August 2026.	10 Jul 2026	✓ Kept
	“proposing a return of capital of up to £30 million to Shareholders by way of a Tender Offer” Result 35.3m shares bought at 85p for £30m on 11 August 2026. “a total of 35,294,117 Shares will be purchased under the Tender Offer at the Tender Price of 85 pence per Share. The total value to be returned to Shareholders pursuant to the Tender Offer will therefore be approximately £30 million.”11 Aug 2026 · Results of Tender Offer and Total Voting Rights
14 Sep 2026	Complete £10m buyback before interim results.	31 Mar 2026	✓ Kept
	“The Share Buyback Programme is expected to commence on 31 March 2026 and be completed before the Company's Interim Results are published.” Result A £5m buyback started 23 June, the £30m tender completed in August, and £5m of buybacks were completed by 2 October 2026. “Following the above transaction, the Company has completed the Share Buyback Programme which was announced on 23 June 2026. In total, the Company repurchased 6,702,016 ordinary shares of £0.0001, all of which were cancelled, at a total cost of approximately £5 million.”2 Oct 2026 · Completion of Share Buyback Programme
Today · 10 Oct 2026
31 Dec 2026	Reach £500m annualised revenue by end of 2026 via organic growth and M&A.	4 Mar 2024	… In progress
	“Targeting annualised revenue of £500m by the end of 2026, through a combination of high single to double-digit organic revenue growth and M&A.” Also stated 31 Jul 2024 · 10 Mar 2025 Status so far Not yet due.
31 Dec 2026	Progress to 45% Adjusted EBITDA margin over the plan period to end-2026.	4 Mar 2024	✗ Missed · target changed
	“progress towards 45% Adjusted EBITDA margin over the course of our 3-year plan” Also stated 31 Jul 2024 Result Margin fell to 34% in FY25; target replaced by recovery towards 40%, now described as 'more measured'. “Margin Recovery and Expansion: Recover Adjusted EBITDA margins towards 40%, leading to high cash conversion and strong returns on invested capital.”2 Mar 2026 · Final Results “The Board believes that investment at this time to support revenue growth is in the best interests of long-term value creation and therefore expects a more cautious recovery in margins in the medium term than previously stated.”14 Sep 2026 · Half-year Results
31 Dec 2026	Add more than 150 front-line salespeople during the plan.	31 Jul 2024	… In progress
	“expand our front-line sales teams by more than 150 additional salespeople during the Growth Transformation Plan” Status so far Not yet due.
31 Dec 2026	Drive Adjusted EBITDA margin back towards 40% in FY26 and beyond.	20 Oct 2025	✗ Missed · target changed
	“The Group continues to expect margins to return towards 40% in 2026.” Also stated 14 Jan 2026 · 2 Mar 2026 · 14 Sep 2026 Result September 2026 guidance called for a 'more measured' recovery, with EBITDA towards the low end of consensus. “The Group expects full year Adjusted EBITDA at the low end of consensus, reflecting planned actions in the second half to accelerate margin.”9 Jul 2026 · Trading Update, Acquisition, Proposed Tender Offer “The Board believes that investment at this time to support revenue growth is in the best interests of long-term value creation and therefore expects a more cautious recovery in margins in the medium term than previously stated.”14 Sep 2026 · Half-year Results
31 Dec 2026	Lift underlying revenue growth to mid-single digits.	2 Mar 2026	… In progress
	“Our immediate priority is to accelerate underlying revenue growth, supported by targeted investment.” Also stated 14 Sep 2026 Status so far Not yet due.